National and Kapodistrian University of Athens
Προγνωστικοί παράγοντες στο μεταπλαστικό καρκίνο του μαστού
Abstract
dc:descriptionBreast cancer is the most common malignancy and the second leading cause of death among women. Metaplastic breast carcinoma (MpBC) is a rare, poorly differentiated type of breast cancer characterized by the presence of ductal carcinoma components along with areas containing matrix-producing cells, spindle-shaped cells, or sarcomatoid or squamous differentiation. In most cases, MpBC lacks hormone receptor expression and carries a poor prognosis. Its incidence ranges from 0.2% to 5%. The Hippo signaling pathway has recently been associated with cancer progression and resistance to adjuvant therapy. The aim of the present study was to evaluate the expression of Hippo pathway effectors TAZ, YAP1, CCND1, and CTGF in MpBC and their correlation with the clinicopathological characteristics of the disease. This pathway is a molecular growth-regulating pathway first discovered in the 1990s in Drosophila melanogaster. Specifically, it plays an essential role in organ size control, tissue regeneration, wound healing, and stem cell self-renewal by maintaining a balance between cell proliferation and apoptosis. The Hippo pathway includes the kinases MST1/2 and LATS1/2. When the pathway is active, it leads to the inactivation (via phosphorylation) of TAZ/YAP, resulting in their binding to the 14-3-3 protein, their retention in the cytoplasm, and their subsequent degradation. In contrast, when the pathway is inactive, TAZ/YAP translocate into the nucleus, interact with target genes, and promote tumorigenesis. This is a retrospective study, in which formalin-fixed paraffin-embedded (FFPE) tissue samples were collected from 44 women with MpBC who were treated in our department, and were analyzed using immunohistochemistry and real-time PCR. Strong nuclear YAP/TAZ expression was found in 61.4%% (27/44) of the included patients. Expression of CCND1 and CTGF genes were 3.9% and 12.5% respectively. Patients presenting at an advanced stage had a statistically worse prognosis compared to the ones diagnosed with stage IA disease. Adjuvant chemotherapy was associated with better overall survival, while disease recurrence was significantly associated with a worse prognosis. Advanced stage at diagnosis and disease recurrence were significantly associated with worse prognosis in MpBC. However, adjuvant chemotherapy significantly led to better overall survival. The Hippo pathway is frequently deregulated (nuclear YAP/TAZ in 61.4% of patients), suggesting it is a compelling novel therapeutic target for this aggressive disease.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papamattheou, Eleni
- Παπαματθαίου, Ελένη
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61672